 National Post |
News in Brief: Allergy, Asthma and Immunology Meeting
Science News People with hives that recur for years and even decades might get relief from an allergy drug. Called omalizumab and marketed as Xolair, the drug inhibits the rogue antibody immunoglobulin E, which brings on persistent, intense itching and body … C-Section May Raise Child's Risk of Allergies, Asthma: Study Environmental factors appear to promote development of allergic diseases Researchers share findings on allergies at national meeting in San Antonio |
View full post on asthma – Google News